Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist for the treatment of acromegaly; CRN04894, an oral adrenocorticotrophic hormone antagonist for the treatment of Cushing's and congenital adrenal hyperplasia diseases, etc.